Connective tissue growth factor and regulation of the mesangial cell cycle: Role in cellular hypertrophy

Journal of the American Society of Nephrology

Volumn 13, Issue 10, 2002, Pages 2437-2445

  Wahab, Nadia Abdel ^a   Weston, Benjamin S ^a   Roberts, Terry ^a   Mason, Roger M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CONNECTIVE TISSUE GROWTH FACTOR; CYCLIN D; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; PROTEIN P15; PROTEIN P21; PROTEIN P27; RETINOBLASTOMA PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL STIMULATION; COMPLEX FORMATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME INACTIVATION; ENZYME INDUCTION; HUMAN; HUMAN CELL; HYPERTROPHY; MESANGIUM CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INDUCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION;

EID: 0036786249     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000031828.58276.02     Document Type: Article

References (72)

1. Kreisberg JI, Ayo SH: The glomerular mesangium in diabetes mellitus. Kidney Int 43: 109-113, 1993
2. Hostetter TH: Progression of renal disease and renal hypertrophy. Annu Rev Physiol 57: 263-278, 1995
3. Wolf G, Ziyadeh FN: Molecular mechanism of diabetic renal hypertrophy. Kidney Int 56: 393-405, 1999
4. Wolf G, Sharma K, Chen Y, Ericksen M and Ziyadeh FN: High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β. Kidney Int 42: 647-656, 1992
5. Wolf G, Schroeder R, Zahner G, Stahl RAK, Shankland SJ: High glucose-induced hypertrophy of mesangial cells requires p27 Kip1, an inhibitor of cyclin-dependent kinases. Am J Pathol 158: 1091-1100, 2001
6. Hannon GJ, Beach D: p15INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371: 257-260, 1994
7. Li JM, Nichols MA, Chandrasekharan S, Xiong Y, Wang XF: Transforming growth factor-β activates the promoter of cyclin-dependent kinase inhibitor p15INK4B through an Sp1 consensus site. J Biol Chem 270: 26750-26753, 1995
8. Wolf G, Wenzel U, Ziyadeh FN, Stahl RAK: ACE inhibitor treatment reduces glomerular p16INK4 and p27Kip1 expression in diabetic BBdp rats. Diabetologia 42: 1424-1432, 1999
9. Kuan CJ, Al-Douahji M, Shankland SJ: The cyclin kinase inhibitor p21 WAF1, CIP1 is increased in experimental diabetic nephropathy: Potential role in glomerular hypertrophy. J Am Soc Nephrol 9: 986-993, 1998
10. Li CY, Suardet L, Little JB: Potential role of WAF1/CiP1/p21 as a mediator of TGF-β cytoinhibitory effect. J Biol Chem 270: 4971-4974, 1995
11. Wolf G, Schroeder R, Ziyadeh FN, Thaiss F, Zahner G, Stahl RAK: High glucose stimulates expression of p27Kip1 in cultured mouse mesangial cells: Relationship to hypertrophy. Am J Physiol Renal Physiol 273: F348-F356, 1997
12. Polyak K, Kato J, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A: p27Kip1, a cyclin-CDK inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 8: 9-22, 1994
13. Shankland SJ, Scholey JW: Expression of transforming growth factor-β1 during diabetic renal hypertrophy. Kidney hit 46: 430-442, 1994
14. Rabkin R, Fervenza FC: Renal hypertrophy and kidney disease in diabetes. Diabetes Metab Rev 12: 217-241, 1996
15. Shankland SJ, Wolf G: Cell cycle regulatory proteins in renal diseases: Role in hypertrophy, proliferation, and apoptosis. Am J Physiol Renal Physiol 278: F515-F529, 2000
16. Moussad EEA, Brigstock DR: Connective tissue growth factor: What's in a name? Mol Gene Metab 71: 276-292, 2000
17. Frazier K, Williams S, Kothapalli D, Klapper H, Grotendorst GR: Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 107: 404-411, 1996
18. Shimo T, Nakanishi T, Nishida T, Asano M, Kanyama M, Kuboki T, Tamatani T, Tezuka K, Takemura M, Matsumura T, Takigawa M: Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cell in vitro, and angiogenesis in vivo. J Biol Chem 126: 137-145, 1999
19. Bradham DM, Igarashi A, Potter RL, Grotendorst GR: Connective tissue growth factor: A cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 114: 1285-1294, 1991
20. Babic AM, Chen CC, Lau, LF: Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol 19: 2985-2966, 1999
21. Blom IE, van Dijk AJ, Wieten L, Duran K, Ito Y, Kleij L, deNichilo M, Rabelink TJ, Weening JJ, Aten J, Goldschmeding R: In vitro evidence for differential involvement of CTGF, TGF-beta, and PDGF-BB in mesangial response to injury. Nephrol Dial Transplant 16: 1139-1148, 2001
22. Haberberger TC, Kupfer K, Murphy JE: Profiling of genes which are differentially expressed in mouse liver in response to adenoviral vectors and delivered genes. Gene Ther 7: 903-909, 2000
23. Hishikawa K, Nakaki T, Fujii T: Connective tissue growth factor induces apoptosis via caspase 3 in cultured human aortio-smooth muscle cells. Eur J Pharmacol 392: 19-22, 2000
24. Dammeier J, Brauchle M, Falk W, Grotendorst GR, Werner S: Connective tissue growth factor: A novel regulator of mucosal repair and fibrosis in inflammatory bowel disease? Int J Biochem Cell Biol 30: 909-922, 1998
25. Riser BL, Denichilo M, Cortes P, Baker C, Grondin JM, Yee J, Natrins RG: Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol 11: 25-38, 2000
26. Murphy M, Godson C, Cannon S, Kato S, Mackenzie HS, Martin F, Brady HR: Suppression subtractive hybridization identifies high glucose level as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 274: 5830-5834, 1999
27. Abdel-Wahab N, Yevdokimova N, Weston BS, Roberts T, Jun Li X, Brinkman H, Mason RM: Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy. Biochem J 359: 77-87, 2001
28. Ito Y, Aten J, Bende RJ, Oemar BS, Rabelink TJ, Weening JJ, Goldschmeding R: Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 53: 853-861, 1998
29. Abdel Wahab N, Harper K, Mason RM: Expression of extracellular matrix molecules in human mesangial cells in response to prolonged hyperglycaemia. Biochem J 316: 985-992, 1996
30. Xiao H, Hasegawa T, Miyaishi O, Ohkusu K, Isobe K: Sodium butyrate induces NIH3T3 cells to senescence-like state and enhances promoter activity of p21 WAF/CIP1 in p53-independent manner. Biochem Biophys Res Commun 237: 457-460, 1997
31. Schoecklmann HO, Rupprecht HD, Zauner I, Sterzel RB: TGF-β1 induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk 2 activation and retinoblastoma protein phosphorylation. Kidney Int 51: 1228-1236, 1997
32. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81: 323-330, 1995
33. Franch HA, Shay JW, Alpern RJ, Preising PA: Involvement of pRb family in TGF-beta-dependent epithelial cell hypertrophy. J Cell Biol 129: 245-254, 1995
34. Riley DJ, Lee EY-HP, Lee W-H: The retinoblastoma protein: More than a tumor suppressor. Annu Rev Cell Biol 10: 1-29, 1994
35. Lavoie JN, L'Allemain G, Brunet A, Muller R, Pouyssegur J: Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HPGMAK pathway. J Biol Chem 271: 20608-20616, 1996
36. Alt JR, Cleveland JL, Hannink M, Diehl JA: Phosphorylation dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev 14: 3102-3114, 2000
37. Nguyen H, Gitig DM, Koff A: Cell-free degradation of p27(Kip1), a G1 cyclin-dependent kinase inhibitor, is dependent an CDK2 activity and the proteasome. Mol Cell Biol 19: 1190-1201, 1999
38. Cip1. Mol Cell Biol 17: 5588-5597, 1997
39. War1/Cip1. Nature 394: 295-299, 1998
40. Ko LJ, and Prives C: p53: Puzzle and paradigm. Genes Dev 10: 1054-1072, 1996
41. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993
42. Sarkaria JN, Tibbetts RS, Busby EC, Kennedy AP, Hill DE, Abraham RT: Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin. Cancer Res 58: 4375-4382, 1998
43. Kim ST, Lim DS, Canman CE, Kastan MB: Substrate specificities and identification of putative substrates of ATM kinase family members. J Biol Chem 274: 37538-37543, 1999
44. Shieh SY, Ikeda M, Taya Y, Prives C: DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91: 325-334, 1997
45. Gottifred V, Shieh SY, Taya Y, Prives C: p53 accumulates but is functionally impaired when DNA synthesis is blocked. Proc Natl Acad Sci USA 98: 1036-1041, 2001
46. Dumaz N, Meek DW: Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J 18: 1805-1814, 1999
47. el-Deiry WS, Tokino T, Waldman T, Oliner J-D, Velculescu VE, Burrell M, Hill DE, Heady E, Rees JL, Hamilton SR, Kinzer KW, Vogelstein B: Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res 55: 2910-2919, 1995
48. Norbury C, Nurse P: Animal cell cycles and their control. Annu Rev Biochem 61: 441-471, 1992
49. Nasmyth K: Viewpoint: Putting the cell cycle in order. Science 274: 1643-1645, 1996
50. Fine JG: The biology of renal hypertrophy. Kidney Int 29: 619-634, 1986
51. Fine LG, Norman J: Cellular events in renal hypertrophy. Annu Rev Physiol 51: 19-32, 1989
52. Shankland SJ: Cell cycle control and renal disease. Kidney Int 52: 294-308, 1997
53. Morgan DO: Principles of CDK regulation: Nature 374: 131-134, 1995
54. Sherr CJ: G1 phase progression: Cycling on cue. Cell 79: 551-555, 1994
55. Sherr CJ: Mammalian G1 cyclins. Cell 73: 1059-1065, 1993
56. Solomon MJ, Kaldis P: Regulation of CDKs by phosphorylation. In: Cell Cycle Controls, edited by M. Pagano, Berlin, Springer, 1998
57. Sherr CJ, Roberts JM: CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512, 1999
58. 1 cell-cycle progression by oncogenes and tumor suppressor genes. Curr Opin Genet Dev 12: 47-52, 2002
59. 1 cyclin-dependent kinase complexes in vivo. Mol Cell Biol 21: 4773-4784, 2001
60. Fantl V, Stamp G, Andrews A, Rosewell I, Dickson C: Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev 9: 2364-2372, 1995
61. Datar SA, Jacobs HW, de la Cruz AFA, Lehner CF, Edgar BA: The Drosophila cyclin D-Cdk4 complex promotes cellular growth. EMBO J 19: 4543-4554, 2000
62. Preisig P: A cell cycle-dependent mechanism of renal tubule epithelial cell hypertrophy. Kidney Int 56: 1193-1198, 1999
63. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J Clin Invest 93: 536-542, 1994
64. Young BA, Johnson RJ, Alpers CE, Eng E, Gordon K, Floege J, Couser WG, Seidel K: Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 47: 935-944, 1995
65. Sharma K, Jin Y, Guo J, Ziyadeh FN: Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45: 522-530, 1996
66. Hishikawa K, Oemar BS, Nakaki T: Static pressure regulates connective tissue growth factor expression in human mesangial cells. J Biol Chem 276: 16797-16803, 2001
67. Ophascharoensuk V, Fero ML, Hughes J, Roberts JM, Shankland SJ: The cyclin-kinase inhibitor p27Kipl safeguards against inflammatory injury. Nature Med 4: 575-580, 1998
68. el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B: Definition of a consensus binding site for p53. Nature Genet 1: 45-49, 1992
69. Wang S, DeNichilo M, Brubaker and Hirschberg R: Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy. Kidney Int 60: 96-105, 2001
70. Fan W-H, Karnovsky MJ: Increased MMP-2 expression in CTGF over-expression vascular smooth muscle cells. J Biol Chem, 277: 9800-9805, 2002
71. Wang L, Wu Q, Qiu P, Mirza A, McGuirk M, Kirschmeier P, Greene JR, Wang Y, Pickett CB, Liu S: Analyses of p53 target genes in the human genome by bioinformatic and microarray approaches. J Biol Chem 276: 43604-43610, 2001
72. Kothapalii D, Grotendorst GR: CTGF modulates cell cycle progression in cAMP-arrested NRK fibroblasts. J Cell Physiol 182: 119-126, 2000